# Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)

> **NCT01594827** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 29 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Inhaled Vancomycin
- **DRUG:** Placebo (Sterile Water)
- **DRUG:** Rifampin
- **DRUG:** Trimethoprim/Sulfamethoxazole (TMP/SMX)
- **DRUG:** Doxycycline
- **DRUG:** Mupirocin Intranasal Creme
- **DRUG:** 4% chlorhexidine gluconate liquid skin cleanser

## Key facts

- **NCT ID:** NCT01594827
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2017-12-30
- **Final completion:** 2017-12-30
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2019-02-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01594827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01594827, "Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01594827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*